Core B, the Data Management and Analysis Core (DMAC) has two primary sets of responsibilities, which may be viewed as specific aims: (a) data management, and (b) data analysis. We have extended the capabilities of Core B to act as a clearinghouse for all clinical, genetic and phenotypic data. In this fashion, Core B will effectively be the centralized group that tracks all data and its sources. The Core is available to the Principal Investigators of the other Cores and Projects for: (a) obtaining human specimens, including both DMA (blood) and surgical tissue specimens;(b) obtaining associated clinical, demographic and detailed phenotypic data associated with specimens;(c) managing and checking the flow of information into the database resources of Core B;and (d) providing datasets for statistical analysis and support. This core structure will allow for optimal coordination of the clinical and basic science research programs by providing a single centralized resource. All projects and Core C monitor and select what samples and/or data may be available for their use. Projects will use Core B to arrange obtaining specimens from either the UCSF DMA bank or the Core C surgical tissue bank. Data analysis includes biostatistical data analysis, data cleaning, quality assurance, monitoring patient recruitment and retention, and preparation of interim reports. Optimal biostatistical analysis also includes involvement in experimental design issues. Core B will also assist in preparation of manuscripts and presentations.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Program Projects (P01)
Project #
5P01NS044155-10
Application #
8451442
Study Section
National Institute of Neurological Disorders and Stroke Initial Review Group (NSD)
Project Start
Project End
Budget Start
2013-04-01
Budget End
2014-03-31
Support Year
10
Fiscal Year
2013
Total Cost
$259,078
Indirect Cost
$91,462
Name
University of California San Francisco
Department
Type
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Weinsheimer, Shantel; Bendjilali, Nasrine; Nelson, Jeffrey et al. (2016) Genome-wide association study of sporadic brain arteriovenous malformations. J Neurol Neurosurg Psychiatry 87:916-23
Zhang, Rui; Zhu, Wan; Su, Hua (2016) Vascular Integrity in the Pathogenesis of Brain Arteriovenous Malformation. Acta Neurochir Suppl 121:29-35
Brand, Oliver J; Somanath, Sangeeta; Moermans, Catherine et al. (2015) Transforming Growth Factor-β and Interleukin-1β Signaling Pathways Converge on the Chemokine CCL20 Promoter. J Biol Chem 290:14717-28
Yang, Shun-Tai; Rodriguez-Hernandez, Ana; Walker, Espen J et al. (2015) Adult mouse venous hypertension model: common carotid artery to external jugular vein anastomosis. J Vis Exp :50472
Wang, Liang; Shi, Wanchao; Su, Zhiguo et al. (2015) Endovascular treatment of severe acute basilar artery occlusion. J Clin Neurosci 22:195-8
Potts, Matthew B; Lau, Darryl; Abla, Adib A et al. (2015) Current surgical results with low-grade brain arteriovenous malformations. J Neurosurg 122:912-20
Hashimoto, Mitsuo; Yanagisawa, Haruhiko; Minagawa, Shunsuke et al. (2015) A critical role for dendritic cells in the evolution of IL-1β-mediated murine airway disease. J Immunol 194:3962-9
Kremer, P H C; Koeleman, B P C; Pawlikowska, L et al. (2015) Evaluation of genetic risk loci for intracranial aneurysms in sporadic arteriovenous malformations of the brain. J Neurol Neurosurg Psychiatry 86:524-9
Hashimoto, Mitsuo; Yanagisawa, Haruhiko; Minagawa, Shunsuke et al. (2015) TGF-β-Dependent Dendritic Cell Chemokinesis in Murine Models of Airway Disease. J Immunol 195:1182-90
Guo, Yi; Tihan, Tarik; Kim, Helen et al. (2014) Distinctive distribution of lymphocytes in unruptured and previously untreated brain arteriovenous malformation. Neuroimmunol Neuroinflamm 1:147-152

Showing the most recent 10 out of 126 publications